Negara: Malta
Bahasa: Inggris
Sumber: Malta Medicines Authority
PROPOFOL
Primex Pharmaceuticals Oy Mariankatu 21C, 00170 Helsinki, Finland
N01AX10
PROPOFOL 20 mg/ml
EMULSION FOR INFUSION OR INJECTION
PROPOFOL 20 mg/ml
POM
ANESTHETICS
Withdrawn
2009-06-08
Page 1 of 14 PACKAGE LEAFLET: INFORMATION FOR THE USER RECOFOL N 20 MG/ML EMULSION FOR INJECTION OR INFUSION Propofol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. – Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor or pharmacist. – If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Recofol N 20 mg/ml is and what it is used for 2. Before you use Recofol N 20 mg/ml 3. How to use Recofol N 20 mg/ml 4. Possible side effects 5. How to store Recofol N 20 mg/ml 6. Further information 1. WHAT RECOFOL N 20 MG/ML IS AND WHAT IT IS USED FOR Recofol N 20 mg/ml belongs to a group of medicines called general anaesthetics. General anaesthetics are used to cause unconsciousness (sleep) so that surgical operations or other procedures can be per- formed. They can also be used to sedate you (so that you are sleepy but not completely asleep) Recofol N 20 mg/ml is used to – induce and maintain general anaesthesia in adults and children > 3 years – sedate patients > 16 years of age receiving artificial respiration in intensive care – sedate adults and children > 3 years during diagnostic and surgical procedures, alone or in combina- tion with local or regional anaesthesia. 2. BEFORE YOU USE RECOFOL N 20 MG/ML DO NOT USE RECOFOL N 20 MG/ML: – if you are allergic (hypersensitive) to propofol, soya, peanuts or to any of the other ingredients of Recofol N 20 mg/ml. – in patients of 16 years of age or younger for sedation during intensive care. TAKE SPECIAL CARE WITH RECOFOL N 20 MG/ML – if you have a disorder in which your body does not h Baca dokumen lengkapnya
Page 1 of 12 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Recofol N 20 mg/ml emulsion for injection or infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml emulsion for injection or infusion contains: Propofol 20 mg Thus, one vial of 50 ml contains : 1 000 mg propofol Excipients: 1 ml emulsion for injection or infusion contains: Soya-bean oil refined 50 mg Sodium 0.03 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Emulsion for injection or infusion White, milky oil-in-water emulsion 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Recofol 20 mg/ml is a short-acting intravenous general anaesthetic for induction and maintenance of general anaesthesia in adults and children > 3 years sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 3 years edation of ventilated patients >16 years of age in the intensive care unit. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION WARNING Recofol N 20 mg/ml must only be given in hospitals or adequately equipped day therapy units by physicians trained in anaesthesia or in the care of patients in intensive care. Circulatory and respiratory functions should be constantly monitored (e.g. ECG, pulse-oxymeter) and facilities for maintenance of patent airways, artificial ventilation, and other resuscitation facilities should be immediately available at all times. For sedation during surgical or diagnostic procedures Recofol N 20 mg/ml should not be given by the same person that carries out the surgical or diagnostic procedure. Supplementary analgesic medicinal products are generally required in addition to Recofol N 20 mg/ml. Baca dokumen lengkapnya